Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmacogenomics

Showing results (1-10 of 3,373) with videos related to

Pageof 338
Sort By:
Pharmacogenomics|November 4, 2022
CYP2C18: the orphan in the CYP2C familyPablo Zubiaur, Andrea Gaedigk
Pharmacogenomics|June 9, 2016
ABCB1 1199G>A polymorphism (rs2229109) affects the transport of imatinib, nilotinib and dasatinibGéraldine Dessilly, Laure Elens, Nadtha Panin, et al.
Pharmacogenomics|June 9, 2016
Efflux transporter variants as predictors of drug toxicity in lung cancer patients: systematic review and meta-analysisZoulikha M Zaïr, Donald Rj Singer
Pharmacogenomics|August 1, 2015
Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipientsJia-li Li, Shu Liu, Qian Fu, et al.
Pharmacogenomics|August 13, 2015
Dissecting ancestry genomic background in substance dependence genome-wide association studiesRenato Polimanti, Can Yang, Hongyu Zhao, et al.
Pharmacogenomics|May 5, 2016
Could personalized management of menopause based on genomics become a reality?Ann M Moyer, Virginia M Miller, Stephanie S Faubion
Pharmacogenomics|May 5, 2016
Differences in genetic variants in lopinavir disposition among HIV-infected Bantu AfricansBafokeng Mpeta, Elizabeth Kampira, Sandra Castel, et al.
Pharmacogenomics|May 5, 2016
Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrationsJ Kevin Hicks, Blanca E Gonzalez, Anthony S Zembillas, et al.
Pharmacogenomics|December 1, 2015
Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysisJing Shi, Min Xie, Jianmiao Wang, et al.
Pharmacogenomics|December 1, 2015
Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritisYogita Ghodke-Puranik, Amrutesh S Puranik, Pooja Shintre, et al.
Pageof 338

Showing results (1-10 of 3,373) with videos related to

Sort By:
Pageof 338
Pharmacogenomics|November 4, 2022
CYP2C18: the orphan in the CYP2C familyPablo Zubiaur, Andrea Gaedigk
Pharmacogenomics|June 9, 2016
ABCB1 1199G>A polymorphism (rs2229109) affects the transport of imatinib, nilotinib and dasatinibGéraldine Dessilly, Laure Elens, Nadtha Panin, et al.
Pharmacogenomics|June 9, 2016
Efflux transporter variants as predictors of drug toxicity in lung cancer patients: systematic review and meta-analysisZoulikha M Zaïr, Donald Rj Singer
Pharmacogenomics|August 1, 2015
Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipientsJia-li Li, Shu Liu, Qian Fu, et al.
Pharmacogenomics|August 13, 2015
Dissecting ancestry genomic background in substance dependence genome-wide association studiesRenato Polimanti, Can Yang, Hongyu Zhao, et al.
Pharmacogenomics|May 5, 2016
Could personalized management of menopause based on genomics become a reality?Ann M Moyer, Virginia M Miller, Stephanie S Faubion
Pharmacogenomics|May 5, 2016
Differences in genetic variants in lopinavir disposition among HIV-infected Bantu AfricansBafokeng Mpeta, Elizabeth Kampira, Sandra Castel, et al.
Pharmacogenomics|May 5, 2016
Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrationsJ Kevin Hicks, Blanca E Gonzalez, Anthony S Zembillas, et al.
Pharmacogenomics|December 1, 2015
Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysisJing Shi, Min Xie, Jianmiao Wang, et al.
Pharmacogenomics|December 1, 2015
Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritisYogita Ghodke-Puranik, Amrutesh S Puranik, Pooja Shintre, et al.
Pageof 338